In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment ...
Clinical-stage biotechnology company Monte Rosa Therapeutics Inc. (NASDAQ: GLUE) on Wednesday revealed interim data from an ...
If you're worried about a heart attack, you should already know your cholesterol level. But should you now ask your doctor for a blood test that measures C-reactive protein (CRP)? CRP levels rise when ...
Elevated levels of C-reactive protein (CRP), a biomarker commonly used to assess inflammation, may be associated with an increased risk for depression, new research suggests. Data from 2 general ...
Stocktwits on MSN
Why did GLUE stock surge over 50% in premarket today?
CRP levels below 2 mg/L, a threshold associated with lower cardiovascular risk. ・Safety data were favorable, with adverse ...
Zacks Investment Research on MSN
GLUE stock up 45% on positive interim data on inflammation drug
Monte Rosa Therapeutics GLUE jumped 45.41% following positive interim data from a phase-I study evaluating its immunology and inflammation pipeline candidate, MRT-8102. The candidate is a ...
Further, although serum ferritin is recognized as a proinflammatory biomarker that is frequently elevated in a variety of autoimmune disorders, the role it plays in AAV still needs to be elucidated.
Type 1 diabetes is now accepted to be a chronic immunoinflammatory disorder. Because it is a disease of inflammation—both of the innate and adaptive immune systems—it is perhaps not surprising that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results